Ravi Majeti MD, PhD is the Virginia and D.K. Ludwig Professor, Professor of Medicine (Hematology), and Director of the Institute for Stem Cell Biology and Regenerative Medicine at the Stanford University School of Medicine. He was an undergraduate at Harvard, earned his MD and PhD from UCSF, trained in Internal Medicine at Brigham and Women’s Hospital in Boston, and completed his Hematology Fellowship at Stanford. While at Stanford, he completed post-doctoral training in the laboratory of Irving Weissman, where he investigated AML stem cells. Dr. Majeti directs an active NIH-funded laboratory that focuses on the molecular characterization and therapeutic targeting of leukemia stem cells in human hematologic disorders, particularly AML, and has published >120 peer-reviewed articles. He is a recipient of the Burroughs Wellcome Career Award for Medical Scientists, the Blood Cancer United Scholar Award, and the McCulloch and Till Award from ISEH.
Ravindra Majeti MD, PhD
Stanford University
Stanford, California
United States
Project Title
Targeting the inflammatory GM-CSF pathway in high risk CMML Therapeutic Targeting of DOCK1 for Prevention of Clonal Expansion of TP53-Mutant Clonal Hematopoiesis and Treatment of TP53-Mutant AML
Program
CMML Initiative
Discovery